Interventional oncology is an emerging and rapidly growing offshoot of interventional radiology, which emphasizes on the use of minimally-invasive procedures for the diagnosis, treatment, and palliative care for cancer patients. It uses image-guided technologies such as CT, fluoroscopy or ultrasound to target tumor lesions by making small puncture in the skin. Interventional oncology is generally meant for patients who are not able to respond positively towards the chemotherapy or radiation, or ones are unable to undergo surgery. The global interventional oncology market is expected to grow at a CAGR of 7.7% from 2019 to 2025 to reach $1,506.3 million by 2025.